Prime Hospital Pagadi Opportunity in Thane/Mumbai – Become a Medical Entrepreneur for Just ₹25 Crores!
Key Financials
- Monthly Revenue: ₹1 Crore (from diverse super-specialty services, ensuring consistent cash flow).
- Monthly Expenses: ₹15 Lakhs (covering operations, staff, and utilities—yielding strong profit margins).
- Net Monthly Profit: Approximately ₹85 Lakhs (based on provided figures; full audits available upon inquiry).
- Asking Price: ₹25 Crores (full Pagadi transfer premium; cash-heavy transaction preferred, as loans may be limited for Pagadi properties).
Facilities & Operations
- Bed Capacity: 23-bed ICU, plus modular operating theatres, Cath Lab, pathology lab, and consultant chambers. Includes 102+ medical staff (doctors, nurses, technicians) on payroll.
- Specialties: Cardiology, neurology, oncology, orthopaedics, pulmonology, gastroenterology, urology, general surgery, and critical care.
- Infrastructure: State-of-the-art equipment, 24/7 monitoring, piped gases, full generator backup, in-house pharmacy, and canteen. Modern, hygienic setup on a strategic plot ideal for expansion.
- History & Market Position: Established as a leading super-specialty hospital in the Thane-Bhiwandi region, it serves a dense population with growing healthcare demand, delivering affordable, high-quality care.
Location Advantages
- Situated in Bhiwandi/Thane (Mumbai Metropolitan Region), with excellent connectivity via highways and rail to Mumbai city center (approx. 30-45 mins).
- Proximity to industrial hubs, residential areas, and underserved markets—ideal for scaling services amid rising demand for specialized care.
- Pagadi system adds value, with potential redevelopment incentives under MHADA and DCPR 2034 enhancing future upside.
Why Invest Now?
- Market Boom: India needs 3M more hospital beds by 2025; Thane’s suburbs need 20% more capacity.
- Low Entry Barrier: ₹25 Cr pagadi (refundable) vs. ₹100 Cr+ for new build. Government incentives for foreign investment (100% FDI allowed).
- Risk-Mitigated: Fully operational – inherit revenue streams, compliant licenses (NABH, BMC approvals).
- Exit Strategy: High appreciation; flip in 5 years at 2x value amid 19% sector growth.
Deal Terms
- Pagadi Amount: ₹25 Crores (one-time deposit; nominal/offset monthly rent).
- Tenure: Long-term (25+ years, heritable).
- Closing: 30-60 days; due diligence support provided.
- Eligibility: Open to NRIs/Foreigners/MNCs (FDI compliant); Doctors preferred for operational synergy.
Contact Us to Close the Deal!
